Patients who want the weight loss drug Wegovy should have a BMI of over 35

Patients who want the weight loss drug Wegovy should have a BMI of over 35, experts say. In a DR report, the Danish Society for General Medicine’s spokesperson, Dr. Maria Krüger, said patients’ body mass index (BMI) should be reassessed, as one may not necessarily be ill with a BMI of over 30. For many people, she said this could still be considered healthy and normal. Novo Nordisk’s Wegovy is approved for those with a BMI of 30 and above. If you also have or are at risk of a weight-related disease, it can be approved for a BMI of 27. Meanwhile, the Practicing Doctors Organization chairman, Jørgen Skadborg, said almost 400,000 prescriptions have been given out to patients in Denmark since the drug came into effect in December last year.